Table 1. Clinical characteristics of the 86 study participants
CharacteristicLow HS HS (%) < 5.5 n = 43High HS HS (%) > 5.5 n = 43P‐value
Liver fat (%)2.8 ± 1.713.4 ± 6.4 <0.05
Age (years)52.1 ± 8.452.6 ± 8.00.76
Weight (kg)92.4 ± 11.2102.2 ± 14.0 <0.05
Body mass index (BMI) (kg/m²)29.7 ± 3.232.9 ± 3.4 <0.05
Fasting plasma glucose (mmol/l)5.5 ± 0.55.85 ± 0.6 <0.05
Fasting plasma insulin (FPI) (mU/l)7.6 ± 5.014.0 ± 7.0 <0.05
HOMA‐IR1.9 ± 1.33.7 ± 2.0 <0.05
C‐reactive protein (CRP) (mg/l)2.4 ± 2.83.3 ± 3.30.31
Plasma triglycerides (TG) (mmol/l)1.7 ± 0.62.1 ± 0.8 <0.05
Apolipoprotein B (apoB) (mg/dl)90.2 ± 29.097.4 ± 30.70.30
Total cholesterol (mmol/l)4.9 ± 0.855.1 ± 0.70.31
HDL cholesterol (mmol/l)1.1 ± 0.31.1 ± 0.30.96
Alanine aminotransferase (ALT) (U/l)23.5 ± 9.338.9 ± 28.3 <0.05
Aspartate aminotransferase (AST) (U/l)21.9 ± 5.123.2 ± 5.80.41
Alkaline phosphatase (ALP) (U/l)63.2 ± 16.770.5 ± 19.30.16
γ‐glutamyl transferase (GT) (U/l)27.6 ± 16.431.2 ± 13.90.40
  • Data are presented as means ± SD. P‐value indicates significance level of difference between the subjects with low and high hepatic steatosis (HS). P‐values were calculated using Student's t‐test. Bold text indicate significantly different values.